Fuan Group was initially established in 2004, and successfully listed in Shenzhen Stock Exchange in March ,2011.(Stock code 300194).
Now, Fuan Group becomes a large scaled modern pharmaceutical group integrating intermediates, APIs and formulations. Fuan Group performs parallel development of science, industry and commerce based on Chinese domestic markets.
Fuan as a professional pharmaceutical Group, include 9 subsidiaries with a staff of 1900. All workshops of formulations and APIs are designed in compliance with cGMP standard strictly.
more >
Year of Establishment:
2004
Total Assets(USD):
20,000,000 to 24,999,999
Total Number of Staff:
350 to 399
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Agent,Distributor,Trading Company
R&D capacity:
Annual Turnover(USD):
60,000,000 to 64,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: